Medipharm CEO interview
Perth, Sep 17, 2018 AEST (ABN Newswire) - MMJ PhytoTech Limited (
ASX:MMJ) ("MMJ") is pleased to note the recent interview given by Pat McCutcheon, CEO of MediPharm Labs, Inc. ("MediPharm"), providing a business update ahead of MediPharm's imminent listing on the TSX Venture Exchange.
The interview can be viewed at:
http://m.youtube.com/watch?v=4nGuG268nWA#
MMJ owns 6.9% of MediPharm.
About MMJ Group Holdings Ltd
MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/
| ||
|
